BC
AZN icon

Brinker Capital’s AstraZeneca AZN Stock Holding History

Brinker Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$2.02M Buy
19,107
+1,118
+6% +$115K 0.06% 297
2020
Q1 		$1.61M Buy
17,989
+552
+3% +$52K 0.06% 286
2019
Q4 		$1.74M Buy
17,437
+1,410
+9% +$133K 0.05% 352
2019
Q3 		$1.43M Sell
16,027
-72
-0.4% -$6.24K 0.05% 390
2019
Q2 		$1.33M Buy
16,099
+708
+5% +$55.5K 0.05% 388
2019
Q1 		$1.25M Buy
15,391
+399
+3% +$31.4K 0.05% 387
2018
Q4 		$1.14M Sell
14,992
-1,927
-11% -$150K 0.05% 363
2018
Q3 		$1.34M Sell
16,919
-634
-4% -$48K 0.05% 406
2018
Q2 		$1.23M Sell
17,553
-312
-2% -$22.4K 0.05% 418
2018
Q1 		$1.25M Buy
17,865
+1,458
+9% +$101K 0.05% 409
2017
Q4 		$1.14M Buy
16,407
+1,315
+9% +$88.7K 0.04% 390
2017
Q3 		$1.02M Buy
15,092
+6,732
+81% +$425K 0.04% 404
2017
Q2 		$570K Buy
8,360
+4,233
+103% +$276K 0.03% 490
2017
Q1 		$257K Buy
+4,127
New +$240K 0.01% 827

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Brinker Capital's AZN Position: Q2 2020 in Review

Brinker Capital increased its AstraZeneca (AZN) stake by 6.2% in Q2 2020, buying an estimated $115K and bringing the position to 19,107 shares worth $2.02M. The position accounts for 0.06% of the portfolio, ranked #297.

Brinker Capital first reported a position in AZN in Q1 2017 and has held it in 14 quarters since. 669 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

  • Brinker Capital held 19,107 shares of AstraZeneca worth $2.02M as of Q2 2020.
  • Brinker Capital bought 1,118 AstraZeneca shares in Q2 2020, an estimated $115K.
  • AstraZeneca made up 0.06% of Brinker Capital's portfolio in Q2 2020, its #297 holding.
  • Brinker Capital first reported a position in AstraZeneca in Q1 2017 and has held it in 14 quarters since.
  • 669 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.